1315 Capital Backs USpharma Ltd. with Growth Equity Investment

1315 Capital Invests in Primrose Bio

June 17, 2024

Biotechnology

1315 Capital, a Philadelphia-based healthcare-focused growth equity firm, made a significant equity investment in Primrose Bio to support development and commercial expansion of Primrose’s nucleic acid and protein manufacturing technologies. The funding will accelerate commercialization of the company’s Prima RNApols, Pfenex expression system, and PeliCRM carrier protein for therapeutics and vaccines.

CPS Capital Makes Growth Investment in PharmaSmart International

July 12, 2021

Medical Devices

Toronto-based private equity firm CPS Capital made a strategic growth investment in PharmaSmart International alongside the company’s existing management team. The financing (which included term debt from FirePower Capital and Nicola Wealth) will fund roll‑out of PharmaSmart’s PS-2000D health kiosk platform and accelerate expansion across Canada and the United States.

1315 Capital Provides Growth Financing to ProSciento

September 10, 2020

Healthcare Services

ProSciento, a San Diego–based specialty clinical research organization focused on NASH, diabetes and obesity, closed a growth financing round with healthcare investor 1315 Capital. The capital will support expansion of ProSciento's CRO operations and growth of its patient access solutions, including the NASH PASS registry.

1315 Capital Leads Growth Investment in Experic

October 29, 2024

Pharmaceuticals

Experic, a Cranbury, New Jersey-based CDMO and clinical trial supply services firm, received a growth capital investment led by 1315 Capital with participation from existing investors East Seattle Partners, Harro Höfliger Packaging Systems, Inc., and Kineticos Ventures. The capital will be used to enhance Experic’s manufacturing capabilities and accelerate its international expansion to better serve biopharmaceutical clients.

H.I.G. Capital Makes Strategic Equity Investment in Rising Pharmaceuticals

December 13, 2021

Pharmaceuticals

An affiliate of H.I.G. Capital has made a strategic equity investment in Rising Pharma Holdings and Casper Pharma (together, Rising Pharmaceuticals) to support the company's growth, M&A activity and new product launches. Rising Pharmaceuticals is an asset-light developer and marketer of generic and specialty pharmaceuticals based in New Jersey with a diversified portfolio of over 125 products and a network of 23+ CMO/CDO partners.

The Carlyle Group Makes Growth Investment in Pharmapacks

November 12, 2020

E-Commerce

The Carlyle Group made a strategic growth investment of more than $250 million in Pharmapacks, an ecommerce marketplace enablement platform and large marketplace seller, valuing the company at approximately $1.1 billion. The capital is intended to accelerate Pharmapacks' growth by expanding fulfillment capacity, building out its data and analytics platform, and increasing the number of brand partners; J.P. Morgan served as lender and advisor on the transaction.